Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
This study has been completed.
Study NCT00891878
Information provided by National Cancer Institute (NCI)
First Received on April 30, 2009.
Last Updated on January 20, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
